Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current drug metabolism

• Publication date

  2011-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138920011798357024PMID 21623707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.

  2010cited by this paper
• Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration.

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders

  2010cited by this paper
• Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate.

  2010cited by this paper
• Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux

  2010cited by this paper
• Aryl Hydrocarbon Receptor Is a Transcriptional Activator of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

  2010cited by this paper
• Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function

  2009cited by this paper
• Blood−brain barrier transporters and response to CNS-active drugs

  2009cited by this paper
• P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib

  2009cited by this paper
• Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.

  2009cited by this paper
• Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line

  2009cited by this paper
• The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice

  2009cited by this paper
• An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)

  2009cited by this paper
• Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells.

  2009cited by this paper
• The drug transporter-metabolism alliance: uncovering and defining the interplay.

  2009cited by this paper
• Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy Humans

  2009cited by this paper
• Human Brain Imaging and Radiation Dosimetry of 11C-N-Desmethyl-Loperamide, a PET Radiotracer to Measure the Function of P-Glycoprotein

  2009cited by this paper
• Imaging the Function of P‐Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications

  2009cited by this paper
• Pregnane X Receptor (PXR) Regulates P-Glycoprotein at the Blood-Brain Barrier: Functional Similarities between Pig and Human PXR

  2009cited by this paper
• ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier

  2008cited by this paper
• Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria

  2008cited by this paper
• Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy

  2008cited by this paper
• Effect of chronic exposure to morphine on the rat blood–brain barrier: focus on the P‐glycoprotein

  2008cited by this paper
• Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.

  2008cited by this paper
• Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier.

  2008cited by this paper
• Differential expression of the multidrug resistance‐related proteins ABCb1 and ABCc1 between blood‐brain interfaces

  2008cited by this paper
• Role of CYP1B1 in glaucoma.

  2008cited by this paper
• Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.

  2007cited by this paper
• Influence of breast cancer resistance protein (Abcg2) and p‐glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood–brain barrier

  2007cited by this paper
• Expression of the ATP-binding Cassette Membrane Transporter, ABCG2, in Human and Rodent Brain Microvessel Endothelial and Glial Cell Culture Systems

  2007cited by this paper
• Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy.

  2007cited by this paper
• Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

  2007cited by this paper
• P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of Topotecan

  2007cited by this paper
• Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines

  2007cited by this paper
• In Vivo Activation of Human Pregnane X Receptor Tightens the Blood-Brain Barrier to Methadone through P-Glycoprotein Up-Regulation

  2006cited by this paper
• Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate.

  2006cited by this paper
• Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes

  2006cited by this paper
• Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues.

  2006cited by this paper
• In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain

  2006cited by this paper
• Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.

  2006cited by this paper
• Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists.

  2005cited by this paper
• Induction of phase I, II and III drug metabolism/transport by xenobiotics

  2005cited by this paper
• ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier.

  2005cited by this paper
• The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.

  2005cited by this paper
• Immunohistochemical Localization of P-glycoprotein in Rat Brain and Detection of Its Increased Expression by Seizures Are Sensitive to Fixation and Staining Variables

  2005cited by this paper
• Multidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier

  2004cited by this paper
• Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier.

  2004cited by this paper
• Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.

  2004cited by this paper
• Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells

  2004cited by this paper
• Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes.

  2004cited by this paper
• Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.

  2004cited by this paper
• Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

  2004cited by this paper
• Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier.

  2004cited by this paper
• Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1

  2004cited by this paper
• ABC transporters and the blood-brain barrier.

  2004cited by this paper
• The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.

  2004cited by this paper
• Differential expression of multidrug resistance genes in naïve rat brain.

  2003cited by this paper
• Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.

  2003cited by this paper
• Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+-ATPase inhibitors and other xenobiotics

  2003cited by this paper
• Utility of Mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and development.

  2003cited by this paper
• Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data.

  2003cited by this paper
• Apparent Lack of Mrp1-Mediated Efflux at the Luminal Side of Mouse Blood-Brain Barrier Endothelial Cells

  2003cited by this paper
• Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.

  2003cited by this paper
• CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a)anthracene in endothelial cells.

  2003cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Xenobiotic efflux pumps in isolated fish brain capillaries.

  2002cited by this paper
• Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones

  2002cited by this paper
• Permeability of porcine blood brain barrier to somatostatin analogues

  2002cited by this paper
• Localisation of breast cancer resistance protein in microvessel endothelium of human brain

  2002cited by this paper
• MRP8, A New Member of ABC Transporter Superfamily, Identified by EST Database Mining and Gene Prediction Program, Is Highly Expressed in Breast Cancer

  2001cited by this paper
• MRP Subfamily Transporters and Resistance to Anticancer Agents

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily.

  2001cited by this paper
• Cytochromes P450 in brain: function and significance.

  2001cited by this paper
• Screening of Multidrug-Resistance Sensitive Drugs by In Situ Brain Perfusion in P-Glycoprotein-Deficient Mice

  2001cited by this paper
• Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells.

  2000cited by this paper
• Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

  2000cited by this paper
• Functional expression of p‐glycoprotein and multidrug resistance‐associated protein (mrp1) in primary cultures of rat astrocytes

  2000cited by this paper
• Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain.

  1999cited by this paper
• Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells

  1998cited by this paper
• Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain.

  1998cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Characterization of efflux transport of organic anions in a mouse brain capillary endothelial cell line.

  1998cited by this paper
• Brain Microvascular and Astrocyte Localization of P‐Glycoprotein

  1997cited by this paper
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

  1994cited by this paper
• Localization of Drug‐Metabolizing Enzyme Activities to Blood‐Brain Interfaces and Circumventricular Organs

  1994cited by this paper
• High levels of P-glycoprotein detected in isolated brain capillaries.

  1993cited by this paper
• Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia.

  1990cited by this paper
• Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system.

  1990cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• A new aspect of the protective functions of the blood-brain barrier: activities of four drug-metabolizing enzymes in isolated rat brain microvessels.

  1988cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• Subcellular distribution of cytochrome P-450 in the brain.

  1986cited by this paper
• Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture.

  1982cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper
• DOPAMINE FORMATION IN BRAIN CAPILLARIES—AN ENZYMIC BLOOD–BRAIN BARRIER MECHANISM

  1967cited by this paper

• Computational investigation of the structures and spectroscopic properties of curcumin and its metabolites

  2026cites this paper
• Dolutegravir induces endoplasmic reticulum stress at the blood–brain barrier

  2025cites this paper
• Micro- and Nanoplastics as Neurotoxicants: Mechanistic Insights from Particle Morphology, Circadian Disruption, and Potential Neurodegeneration – A State-of-the-Art Narrative Review

  2025cites this paper
• Dynamic modulation of the blood–brain barrier in the healthy brain

  2025cites this paper
• Lab Protocols for Coxsackievirus B3 Infection Using Brain-Like Endothelial Cells Derived from Induced-Pluripotent Human Stem Cells.

  2025cites this paper
• Ultrasound-Assisted Blood-Brain Barrier Opening Monitoring by Photoacoustic and Fluorescence Imaging Using Indocyanine Green.

  2025cites this paper
• Altered Abundance of Barrier-Related Proteins in Brain Microvascular Endothelial Cells of the GL261 Mouse Model of Glioblastoma.

  2025cites this paper
• Construction of cytochrome P450 3A and P-glycoprotein knockout rats with application in rivaroxaban-verapamil interactions.

  2024cites this paper
• Exploring Kp,uu,BBB Values Smaller than Unity in Remoxipride: A Physiologically-Based CNS Model Approach Highlighting Brain Metabolism in Drugs with Passive Blood-Brain Barrier Transport

  2024cites this paper
• Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier

  2024cites this paper
• Structural basis for substrate and inhibitor recognition of human multidrug transporter MRP4

  2023cites this paper
• Temperature related toxicity features of acute acetamiprid and thiacloprid exposure in Daphnia magna and implications on reproductive performance.

  2023cites this paper
• Cocaine Regulates Antiretroviral Therapy CNS Access Through Pregnane-X Receptor-Mediated Drug Transporter and Metabolizing Enzyme Modulation at the Blood Brain Barrier

  2023cites this paper
• P-glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Main Active Heroin Metabolites 6-monoacetylmorphine (6-MAM) and Morphine in Mice

  2023cites this paper
• Pesticides at brain borders: Impact on the blood-brain barrier, neuroinflammation, and neurological risk trajectories.

  2023cites this paper
• The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure

  2023cites this paper
• The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution—A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling

  2023cites this paper
• Activation of the Wnt/β-catenin/CYP1B1 pathway alleviates oxidative stress and protects the blood-brain barrier under cerebral ischemia/reperfusion conditions

  2023cites this paper
• Role of microRNAs in the regulation of blood-brain barrier function in ischemic stroke and under hypoxic conditions in vitro

  2022cites this paper
• Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues

  2022cites this paper
• Relevance of ABC Transporters in Drug Development.

  2022cites this paper
• Theoretical Study on the Structures, Spectral Properties, and Drugability of Xenicane-type Diterpenoids from Dictyota dichotoma

  2021cites this paper
• Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease.

  2021cites this paper
• Lipid nanocapsules to enhance drug bioavailability to the central nervous system.

  2020cites this paper
• Brain targeting with docosahexaenoic acid as a prospective therapy for neurodegenerative diseases and its passage across blood brain barrier.

  2020cites this paper
• Advances in nanomedicines for diagnosis of central nervous system disorders.

  2020cites this paper
• Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance

  2020cites this paper
• Hypoxic-ischemic related cerebrovascular changes and potential therapeutic strategies in the neonatal brain

  2019influential citation
• Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort

  2019cites this paper
• Blood–Brain Barrier

  2019cites this paper
• Theoretical Prediction of the Complex P-Glycoprotein Substrate Efflux Based on the Novel Hierarchical Support Vector Regression Scheme

  2018cites this paper
• Drug Transport at the Brain and Endothelial Dysfunction in Preeclampsia: Implications and Perspectives

  2018cites this paper
• SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer

  2018cites this paper
• Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood–brain barrier model

  2018cites this paper
• Diesel exhaust particles (DEP) pre-exposure contributes to the anti-oxidant response impairment in hCMEC/D3 during post-oxygen and glucose deprivation damage.

  2017cites this paper
• Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood‐brain barrier

  2017cites this paper
• Spectral and 3D model studies of the interaction of orphan human cytochrome P450 2U1 with substrates and ligands.

  2017cites this paper
• Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures

  2017cites this paper
• Membrane-bound human orphan cytochrome P450 2U1: Sequence singularities, construction of a full 3D model, and substrate docking.

  2017cites this paper
• Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP

  2017cites this paper
• Gender-specific expression of ATP-binding cassette (Abc) transporters and cytoprotective genes in mouse choroid plexus.

  2017cites this paper
• CYP‐mediated drug metabolism in the brain impacts drug response

  2017cites this paper
• Characterizing the Gender Differences of Multidrug-resistance Peptide (MRP) Transporter Expression in Mouse Blood-brain Interfaces

  2017cites this paper
• Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

  2017cites this paper
• Cytochrome P450 2U1, a very peculiar member of the human P450s family

  2017cites this paper
• Physicochemical properties of engineered nanomaterials that influence their nervous system distribution and effects.

  2016cites this paper
• Possible biomarkers modulating haloperidol efficacy and/or tolerability.

  2016cites this paper
• [Drug glucuronidation and disposition in brain].

  2016cites this paper
• Quantitative Aspects of Nanodelivery Across the Blood-Brain Barrier : Exemplified with the Opioid Peptide DAMGO

  2015cites this paper
• Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches

  2015cites this paper
• Quantitative Aspects of Nanodelivery Across the Blood-Brain Barrier Exemplified with the Opioid Peptide

  2015cites this paper
• Translational aspects of blood–brain barrier transport and central nervous system effects of drugs: From discovery to patients

  2015cites this paper
• Hypoxia interferes with aryl hydrocarbon receptor pathway in hCMEC/D3 human cerebral microvascular endothelial cells

  2015cites this paper
• The Role of Abcb5 Alleles in Susceptibility to Haloperidol-Induced Toxicity in Mice and Humans

  2015cites this paper
• Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies.

  2015cites this paper
• The Role of Abcb 5 Alleles in Susceptibility to Haloperidol-Induced Toxicity in Mice and Humans

  2015cites this paper
• Aryl hydrocarbon receptor regulates CYP1B1 but not ABCB1 and ABCG2 in hCMEC/D3 human cerebral microvascular endothelial cells after TCDD exposure.

  2015cites this paper
• Biological effects of contaminants in mussels (Mytilus trossulus) transplanted in northern Baltic Sea coastal areas

  2015cites this paper
• Cerebral Microcirculation: An Introduction

  2015cites this paper
• Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes.

  2015cites this paper
• ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance.

  2014cites this paper
• Physiology and Pathophysiology of Cerebral Microcirculation

  2014cites this paper
• Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain

  2014cites this paper
• Principales modifications pharmacocinétiques chez l’enfant

  2014cites this paper
• Bioavailability of Flavonoids

  2014cites this paper
• Anatomy and Physiology of the Blood–Brain Barriers

  2014cites this paper
• Drug Metabolism at the Blood–Brain and Blood–CSF Barriers

  2014cites this paper
• Extrahepatic targets and cellular reactivity of drug metabolites.

  2014cites this paper
• Interplay of drug metabolizing enzymes with cellular transporters

  2014cites this paper
• Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.

  2014cites this paper
• Compounds blocking methylglyoxal-induced protein modification and brain endothelial injury.

  2014cites this paper
• Extrahepatic metabolism at the body's internal–external interfaces

  2014cites this paper
• In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2)

  2014cites this paper
• Drug Delivery to the Brain

  2014cites this paper
• Drug and xenobiotic biotransformation in the blood–brain barrier: a neglected issue

  2014cites this paper
• 8-Methoxypsoralen is a competitive inhibitor of glutathione S-transferase P1-1

  2014cites this paper
• Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties

  2014cites this paper
• Cyclosporine-inhibitable Cerebral Drug Transport Does Not Influence Clinical Methadone Pharmacodynamics

  2014cites this paper
• Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism

  2014cites this paper
• Heinz Lehmann Award paper Cytochrome P 450 – mediated drug metabolism in the brain

  2013cites this paper
• The Expression and Regulation of CYP2D in a Monkey Model of Ethanol and Nicotine Exposure

  2013cites this paper
• DMD050344 923..931

  2013cites this paper
• Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier

  2013cites this paper
• Preservation, induction or incorporation of metabolism into the in vitro cellular system - views to current opportunities and limitations.

  2013cites this paper
• Drug-Like Property Profiling of Novel Neuroprotective Compounds to Treat Acute Ischemic Stroke: Guidelines to Develop Pleiotropic Molecules

  2013cites this paper
• Investigation of the effect of active efflux at the blood-brain barrier on the distribution of nonsteroidal aromatase inhibitors in the central nervous system.

  2013cites this paper
• Optimisation pharmacologique des dérivés de la créatine pour le traitement du déficit en transporteur de la créatine

  2013cites this paper
• Cytochrome P450-mediated drug metabolism in the brain.

  2013cites this paper
• [Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier].

  2012cites this paper
• HIF-1 at the Blood-Brain Barrier: A Mediator of Permeability?

  2012cites this paper
• Les répercussions de l’insuffisance rénale chronique sur le transport des médicaments

  2012cites this paper
• Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.

  2012cites this paper
• Yeast as a humanized model organism for biotransformation-related toxicity.

  2012cites this paper
• Induction of P‐glycoprotein and Bcrp at the rat blood–brain barrier following a subchronic morphine treatment is mediated through NMDA/COX‐2 activation

  2012cites this paper
• Overview and introduction: The blood–brain barrier in health and disease

  2012cites this paper
• Etablissement et caractérisation de nouveaux modèles in vitro de barrière hémato-encéphalique : de la recherche fondamentale à la recherche appliquée

  2011cites this paper